Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03744156 · ClinicalTrials.gov registry record · NA

Sleep and Pain Interventions in Women With Fibromyalgia

A NA study, sponsored by University of Missouri-Columbia.

Completed
Registry status
NA
Development phase
131
Enrollment target

NCT03744156: Completed NA study, sponsored by University of Missouri-Columbia.

NCT03744156 is a NA study that has completed, run by University of Missouri-Columbia. The registered enrollment target is 131 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03744156, a NA study, has completed, sponsored by University of Missouri-Columbia.

COMPLETED
Registry status
NA
Development phase
131 participants
Enrollment target

Study Summary

Insomnia affects 67-88% of chronic pain patients. SPIN II is a randomized controlled clinical trial that will compare the effects of two cognitive behavioral sleep treatments in women with fibromyalgia and insomnia. This trial will yield important information about the roles of sleep, arousal, and brain structure and function in the development and maintenance of chronic pain in women with fibromyalgia.

Primary Outcome

Participants will answer the following questions on the daily diaries: I napped for \_\_\_\_\_\_\_\_\_\_\_\_ minutes yesterday. I napped \_\_\_\_\_\_ times yesterday. I napped in the \_\_\_morning \_\_\_afternoon \_\_\_\_evening (check all that apply) I went to bed last night at \_\_\_\_\_\_\_\_\_\_\_\_ AM/PM. It took me \_\_\_\_\_\_\_\_\_\_\_\_ minutes to fall asleep. I woke up \_\_\_\_\_\_\_\_\_\_\_\_ times last night. I was awake for \_\_\_\_\_\_\_\_\_\_\_\_ minutes in the middle of the nigh

Interventions

  • BEHAVIORAL Sleep Hygiene Education
  • BEHAVIORAL Cognitive Behavioral Treatment-Insomnia

Trial Details

FieldValue
Enrollment Target 131 participants
Start Date 2019-02-07
Est. Completion 2025-05-31
Phase NA
University of Missouri-Columbia

291 total trials

What the finished NCT03744156 record still lists

NCT03744156 is an interventional study that assigns participants to a tested intervention. The registered 131 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 2 interventions - of which Sleep Hygiene Education is the first listed.

NCT03744156 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03744156 about?

NCT03744156 is a clinical study titled "Sleep and Pain Interventions in Women With Fibromyalgia". Insomnia affects 67-88% of chronic pain patients. SPIN II is a randomized controlled clinical trial that will compare the effects of two cognitive behavioral sleep treatments in women with fibromyalgia and insomnia. This trial will yield important information about the roles of sleep, arousal, and b...

What is the current status of trial NCT03744156?

This trial is currently completed. It is a NA study. The enrollment target is 131 participants. The study started on 2019-02-07. Estimated completion is 2025-05-31.

What interventions are being tested in trial NCT03744156?

The interventions under investigation include: Sleep Hygiene Education (BEHAVIORAL), Cognitive Behavioral Treatment-Insomnia (BEHAVIORAL).

Who is sponsoring clinical trial NCT03744156?

This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03744156's enrollment target sits among peer trials

131 732nd of 2000 higher than 1,268 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03051464 · 131 participants · Phase 2

    No Surgery Trial / Two Dose-escalation Strategies

  • NCT04301843 · 131 participants · Phase 2

    Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma

  • NCT04748549 · 131 participants · NA

    Intraoperative VR for Older Patients Undergoing TKA

  • NCT05951179 · 131 participants · Phase 2

    Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03744156, the US trial registry maintained by the National Library of Medicine. NCT03744156 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.